NRXXY vs. NVO
NRXXY (Nordex SE) and NVO (Novo Nordisk A/S) are both stocks. NRXXY operates in Specialty Industrial Machinery (Industrials), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, NRXXY returned 20.22%/yr vs 2.48%/yr for NVO. Their 0.03 correlation means their historical movements had little consistent relationship.
Performance
NRXXY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NRXXY achieves a 35.07% return, which is significantly higher than NVO's -4.23% return.
NRXXY
- 1D
- 0.00%
- 1M
- -10.87%
- 6M
- 18.31%
- YTD
- 35.07%
- 1Y
- 75.89%
- 3Y*
- 48.94%
- 5Y*
- 20.22%
- 10Y*
- —
- ALL TIME*
- 7.87%
NVO
- 1D
- -8.78%
- 1M
- -6.64%
- 6M
- -18.01%
- YTD
- -4.23%
- 1Y
- 2.25%
- 3Y*
- -14.32%
- 5Y*
- 2.48%
- 10Y*
- 7.55%
- ALL TIME*
- 14.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
NRXXY Nordex SE | $3.08K | $4.95K | $7.81K |
| $504.41M | $480.49M | $577.88M |
NRXXY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
NRXXY Nordex SE | 35.07% | 176.66% | 22.33% | -17.86% | -31.93% | -40.46% |
NVO Novo Nordisk A/S | -4.23% | -39.22% | -15.93% | 54.84% | 22.66% | 64.75% |
Correlation
The correlation between NRXXY and NVO is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.02 |
Correlation (3Y) Balances recent behavior with more history. | 0.03 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.04 |
Correlation (All Time) Calculated using the full available price history since Jan 13, 2021 | 0.03 |
Fundamentals
NRXXY:
$10.96B
NVO:
$209.19B
NRXXY:
€1.07
NVO:
DKK 27.42
NRXXY:
18.81
NVO:
11.15
NRXXY:
0.02
NVO:
0.48
NRXXY:
0.91
NVO:
4.15
NRXXY:
€8.03B
NVO:
DKK 327.80B
NRXXY:
€1.72B
NVO:
DKK 268.30B
NRXXY:
€811.81M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NRXXY vs. NVO — Risk / Return Rank
NRXXY
NVO
NRXXY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nordex SE (NRXXY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NRXXY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.32 | ||
| Sortino ratioReturn per unit of downside risk | +2.13 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.06 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 3.41 | 0.11 | +3.31 |
| Martin ratioReturn relative to average drawdown | 8.13 | 0.20 | +7.93 |
Loading charts...
Drawdowns
NRXXY vs. NVO - Drawdown Comparison
The maximum NRXXY drawdown since its inception was -76.26%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NRXXY and NVO.
Loading charts...
Drawdown Indicators
| NRXXY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.26% | -74.70% | -1.56% |
Max Drawdown (1Y)Largest decline over 1 year | -25.02% | -43.67% | +18.65% |
Max Drawdown (3Y)Largest decline over 3 years | -30.63% | -74.70% | +44.07% |
Max Drawdown (5Y)Largest decline over 5 years | -60.32% | -74.70% | +14.38% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -21.70% | -65.79% | +44.09% |
Average DrawdownAverage peak-to-trough decline | -45.30% | -17.93% | -27.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.42% | 23.97% | -13.55% |
Volatility
NRXXY vs. NVO - Volatility Comparison
The current volatility for Nordex SE (NRXXY) is 11.24%, while Novo Nordisk A/S (NVO) has a volatility of 12.28%. This indicates that NRXXY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NRXXY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.24% | 12.28% | -1.04% |
Volatility (6M)Calculated over the trailing 6-month period | 42.02% | 36.87% | +5.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.21% | 46.77% | +13.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 63.37% | 38.76% | +24.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.27% | 32.76% | +31.51% |
Dividends
NRXXY vs. NVO - Dividend Comparison
NRXXY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.83%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRXXY Nordex SE | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.83% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NRXXY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Nordex SE and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NRXXY vs. NVO - Profitability Comparison
NRXXY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Nordex SE reported a gross profit of 585.03M and revenue of 2.18B. Therefore, the gross margin over that period was 26.9%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
NRXXY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Nordex SE reported an operating income of 225.85M and revenue of 2.18B, resulting in an operating margin of 10.4%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
NRXXY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Nordex SE reported a net income of 111.55M and revenue of 2.18B, resulting in a net margin of 5.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
NRXXY and NVO have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (12.28%) compared to NRXXY (11.24%). In terms of maximum drawdown, NRXXY dropped -76.26% vs NVO's -74.70%.
NRXXY currently has the higher Sharpe Ratio (1.42 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NRXXY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer